ELVN — Enliven Therapeutics, Inc. stock price, charts and financials

QT90Enliven Therapeutics, Inc.

Enliven Therapeutics, Inc. (NASDAQ: ELVN) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
59.42
-1.04-1.72%
OverviewShort InterestFilings
ELVNQT90Enliven Therapeutics, Inc.·NASDAQ
59.42-1.72%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Aug 06, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 06, 20264Statement of changes in beneficial ownership
Aug 05, 20268-KCurrent report
Aug 05, 202610-QQuarterly report
Jul 21, 20264Statement of changes in beneficial ownership
Jul 21, 20264Statement of changes in beneficial ownership
Jul 08, 20264Statement of changes in beneficial ownership
Jun 24, 20264Statement of changes in beneficial ownership
Jun 24, 2026SC 13D/ABeneficial ownership statement (active, amended)
Jun 22, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jun 22, 20264Statement of changes in beneficial ownership
Jun 22, 20264Statement of changes in beneficial ownership
Jun 17, 2026SC 13D/ABeneficial ownership statement (active, amended)
Jun 17, 20264Statement of changes in beneficial ownership
Jun 12, 20268-KCurrent report
Jun 12, 2026424B5Prospectus
Jun 11, 20268-KCurrent report
Jun 11, 2026424B5Prospectus
Jun 10, 20268-KCurrent report
Jun 09, 20264Statement of changes in beneficial ownership
May 20, 20264Statement of changes in beneficial ownership
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
#1 / 25 of 275
Page
▼
/ 11